K Oxiderm OP Post Procedure skin care bruise

Manufacturer
EZEKIELCOSMETIC CO., LTD
Effective date
2017-08-25
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:52:18

Label at a glance#

ProductK Oxiderm OP Post Procedure skin care bruise
Active ingredientMAGNESIUM ASCORBYL PHOSPHATE
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Magnesium Ascorbyl Phosphate

INACTIVE INGREDIENT SECTION

water, propylene glycol, alcohol etc

OTC - PURPOSE SECTION

Reduces Discoloration on skin

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out of reach of the children

INDICATIONS & USAGE SECTION

for 4~5 days before cosmetic application, apply thinly twice a day, morning and night, after cleansing the skin

apply K oxiderm OP cream right after cosmetic application

K oxiderm OP cream is recommended for 10 to 15 days as preparatory skin care before and after surgical and medical cosmetic procedure

WARNINGS SECTION

1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
1) Occurrence of red spots, swelling, itchiness, and other skin irritation
2) If the symptoms above occur after the application area is exposed to direct sunlight
2. Do not use on open wounds, eczema, and other skin irritations
3. Precaution for Storage and Handling
1) Close the lid after use
2) Keep out of reach of infants and children
3) Do not to store in a place with high/low temperature and exposed to direct sunlight

4. Use as avoiding eye areas.

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-138809430533377GTIN-13: 8809430533377
EAN-13: 8809430533377
GTIN storage (14 digits): 08809430533377
label.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71588-0011-12020-01-31C16284748780-19d75b9d0-e4c4-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71588-0011-1K Oxiderm OP Post Procedure skin care bruise30 mL in 1 TUBECREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71588-0011K OXIDERM OP POST PROCEDURE SKIN CARE BRUISE (MAGNESIUM ASCORBYL PHOSPHATE) CREAM [EZEKIELCOSMETIC CO., LTD]1Legacy NDC, 1 package rows20170825_578be57e-cee2-6ec6-e053-2991aa0aba1a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
71588-001171588-0011-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
578be57e-cee3-6ec6-e053-2991aa0aba1a578be57e-cee2-6ec6-e053-2991aa0aba1a2017-08-25WarningsExact identifier
spl id: 578be57e-cee3-6ec6-e053-2991aa0aba1a
spl set id: 578be57e-cee2-6ec6-e053-2991aa0aba1a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.